Germany· DE-A57-3b78975ca625ade1
Moxogamma
A moxonidine product containing moxonidine, registered in Germany by Wörwag Pharma Gmbh & Co. Kg. The same ATC class is registered in 13 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Moxonidine is registered in 13 of 19 countries.
Countries holding a registration under ATC C02AC05 (moxonidine), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 8 of them publish a price we can compare per daily dose
Moxonidine · ATC C02AC05
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of moxonidine costs, country by country.
Normalised to the WHO defined daily dose (0.3 mg), the median price runs from $0.19 in France to $0.70 in Switzerland — a ×3.7 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Moxonidine · price per daily dose (0.3 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.70
- IT Italy$0.35
- FR France$0.19
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Moxonidine
- Manufacturer
- Wörwag Pharma Gmbh & Co. Kg
- Country
- Germany (DE)
- ATC code
- C02AC05
- ATC class
- Moxonidine
- Defined daily dose
- 0.3 mg, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Moxonidine in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCYNTVIATRIS HEALTHCARE LIMITED, Dublin
- United KingdomMoxonidine 200microgram tabletsAlliance Healthcare (Distribution) Ltd
- BelgiumMoxon 0.2 mgViatris
- FinlandMoxonidin ActavisActavis Group ehf.
- PolandPhysiotens 0,2Delfarma Sp. z o.o.
- NetherlandsMoxamar 0,2 mg, filmomhulde tablettenTeva Pharma B.V.
- FranceMOXONIDINE BIOGARAN 0,2 mg, comprimé pelliculéBIOGARAN
- NorwayMoxonidin actavisTeva B.V.
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Moxonibene, Moxonidin Stada
- Belgium · Moxonidine Eg, Moxonidine Sandoz
- Bulgaria · Moxotens, Moксотенс
- Cyprus · Physiotens, Tarwoxin
- Czechia · Cynt, Moxonidin Actavis
- Denmark · Moxonat, Moxonidin Teva
- Estonia · Moxogamma, Moxonidin Actavis
- Spain · Moxon
- Finland · Moxonidin Ratiopharm, Moxonidin Stada
- France · Moxonidine Biogaran, Moxonidine Eg
- United Kingdom (Northern Ireland) · Moxonidine, Moxonidine Generics [uk]
- Greece · Cynt, Fisiotens
- Croatia · Cynt, Moksonidin Belupo
- Hungary · Moxogamma, Moxonidin Ratiopharm
- Italy · Fisiotens, Moxonidina Eg
- Lithuania · Moxogamma, Moxonidin Hexal
- Luxembourg · Moxonidine Eg, Moxonidine Viatris
- Latvia · Moxogamma, Moxonidin Actavis
- Malta · Physiotens
- Netherlands · Moxamar, Moxonidine Pch
- Norway · Moxonidin Actavis, Physiotens
- Poland · Physiotens
- Portugal · Moxon
- Romania · Physiotens
- Sweden · Moxonidin Actavis, Moxonidin Stada
- Slovenia · Filmsko Obložene Tablete, Moxogamma, Moxogamma
- Slovakia · Moxogamma, Moxonidin Ratiopharm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0c36f51d-46e0-4f4d-a448-b4c27afa18ab GET /v1/drugs/0c36f51d-46e0-4f4d-a448-b4c27afa18ab?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Moxonidine",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about moxonidine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.